EMC Capital Management - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
EMC Capital Management ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$417
+244.6%
43,315
+2090.9%
0.31%
+225.5%
Q2 2023$121
-73.5%
1,977
-95.4%
0.09%
-75.5%
Q1 2023$456
-15.1%
43,3150.0%0.38%
-20.5%
Q4 2022$537
-99.9%
43,315
+14.7%
0.48%
+33.1%
Q3 2022$391,000
-10.1%
37,7570.0%0.36%
-2.7%
Q2 2022$435,000
+45.5%
37,757
+51.4%
0.37%
+73.8%
Q1 2022$299,00024,9360.21%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders